Clinical trials: Infra-orbital Hollows, open to volunteers
Infra-orbital Hollows, Skin Quality Improvement
Phase 2 Evaluation of Recombinant Human Platelet-Derived Growth Factor-BB (rhPDGF-BB) Injection for the Treatment of Infraorbital Hollowing
The goal of this Phase 2 clinical trial is to evaluate the safety, tolerability, and preliminary effectiveness of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) injections for the treatment of moderate to severe…
- Trial name
- NCT07914816
- Testing
- RhPDGF-BB, Normal Saline
- Where
- 6 sites in United States
- Volunteers
- 75 people
- Sponsor
- Lynch Regenerative Medicine